We are live on ! Find out more
CTXR icon

Citius Pharmaceuticals
CTXR

30 hedge funds and large institutions have $2.43M invested in Citius Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $244K | Put options by funds: $103K

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

7.75% more ownership

Funds ownership: 0.52% → 8.27% (+7.8%)

47% less funds holding

Funds holding: 57 → 30 (-27)

79% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 34

79% less capital invested

Capital invested by funds: $11.8M → $2.43M (-$9.38M)

Holders
30
Holders Change
-27
Holders Change %
-47.37%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
9
Closed
34
Calls
$244K
Puts
$103K
Net Calls
+$141K
Net Calls Change
+$55K

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$263K
2
UBS Group
UBS Group
Switzerland
+$186K
3
Squarepoint
Squarepoint
New York
+$157K
4
Fisher Asset Management
Fisher Asset Management
Washington
+$86.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$54.2K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$3.64M
2
Osaic Holdings
Osaic Holdings
Arizona
-$241K
3
CCC
Chelsea Counsel Company
California
-$141K
4
HighTower Advisors
HighTower Advisors
Illinois
-$107K
5
WAS
Wealth Advisory Solutions
Indiana
-$101K
Name Holding Trade Value Shares
Change 		Change in
Stake
CFM
51
Catalyst Funds Management
Australia
– -$13.6K -1,088 Closed
Victory Capital Management
52
Victory Capital Management
Texas
– -$10.7K -855 Closed
Financial Engines Advisors
53
Financial Engines Advisors
California
– -$10K -800 Closed
KFS
54
Keynote Financial Services
Connecticut
– -$8.76K -700 Closed
CAG
55
Csenge Advisory Group
Florida
– -$5.51K -600 Closed
Bank of New York Mellon
56
Bank of New York Mellon
New York
– -$7.33K -585 Closed
SA
57
Sanctuary Advisors
Indiana
– -$1.67K -500 Closed
LPL Financial
58
LPL Financial
California
– -$5.75K -459 Closed
EFG
59
Ethos Financial Group
Pennsylvania
– -$5K -400 Closed
BTI
60
Blue Trust Inc
Georgia
– -$1.75K -120 Closed
CSS
61
Cubist Systematic Strategies
Connecticut
– -$651 -52 Closed
AF
62
Allworth Financial
California
– -$151 -12 Closed
APC
63
Aspire Private Capital
North Carolina
– -$150 -12 Closed
EWA
64
EverSource Wealth Advisors
Alabama
– -$8 -1 Closed
Barclays
65
Barclays
United Kingdom
– -$1 – –
1 2
3

CTXR Hedge Fund Activity: Q4 2024 in Review

30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals (CTXR) for Q4 2024, worth a combined $2.43M — down 79% from $11.8M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of CTXR and 7 opened new positions — a net loss of 27 holders — while 9 trimmed existing stakes and 11 added.

The largest buyer was IFP Advisors, adding an estimated $263K. The largest seller was Armistice Capital, exiting entirely with an estimated $3.64M sold.

  • 30 institutional investors held Citius Pharmaceuticals (CTXR) as of Q4 2024, down from 57 in Q3 2024.
  • Funds reported $2.43M of Citius Pharmaceuticals stock for Q4 2024, down 79% quarter-over-quarter.
  • 7 funds opened new Citius Pharmaceuticals positions in Q4 2024 and 34 closed out, a net change of -27 holders.
  • The largest Citius Pharmaceuticals buyer in Q4 2024 was IFP Advisors, an estimated $263K added.
  • The largest Citius Pharmaceuticals seller in Q4 2024 was Armistice Capital, an estimated $3.64M sold.

Based on aggregated 13F filings for Q4 2024.